Item 1A. Risk Factors

There have been no material changes to our risk factors contained in our Annual Report on Form 10-K for the period ended December 31, 2022. For further discussion of our risk factors, refer to Item 1A. "Risk Factors" contained in our Annual Report on Form 10-K for the period ended December 31, 2022.

Item 2 - Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Purchases of Equity Securities

The following table provides information with respect to purchases of our ordinary shares during the second quarter of 2023:


Period	Total number of shares purchased (000's) (a) (b)	Average price paid per share (a) (b)		Total number of shares purchased as part of program (000's) (a)	Approximate dollar value of shares still available to be purchased under the program ($000's) (a)
April 1 - April 30	0.4	$	170.67	—	$	2,899,773
May 1 - May 31	—	168.02		—	2,899,773
June 1 - June 30	4.2	170.36		—	2,899,773
Total	4.6	$	170.38	—

(a) Share repurchases are made from time to time in accordance with management's capital allocation strategy, subject to market conditions and regulatory requirements. In February 2022, our Board of Directors authorized a share repurchase program of up to $3.0 billion of our ordinary shares (2022 Authorization). There were no share repurchases under the 2022 Authorization during the second quarter leaving $2.9 billion remaining.

(b) We may also reacquire shares outside of the repurchase program from time to time in connection with the surrender of shares to cover taxes on vesting of share-based awards. We reacquired 396 shares in April, 18 shares in May, and 4,156 shares in June in transactions outside of the repurchase programs.

Table of Contents

Previous: Item 4. Controls and Procedures · Next: Item 5. Other Information